A carregar...
Aminopyridines for symptomatic treatment in multiple sclerosis
BACKGROUND: The potassium channel blockers 4‐aminopyridine (AP) and 3,4‐diaminopyridine (DAP) increase nerve conduction in demyelinated nerve fibers, and have been proposed as a symptomatic therapy for people with multiple sclerosis (MS). OBJECTIVES: To determine the efficacy and safety of aminopyri...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2002
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7047571/ https://ncbi.nlm.nih.gov/pubmed/11687106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD001330 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|